The Women’s Cancer Research Foundation (WCRF) annually publishes and funds numerous clinical studies on breast and gynecologic (ovarian, endometrial, and cervical) cancers. The WCRF’s oncology experts work tirelessly with the belief that each new clinical study has the potential to fundamentally improve the outcomes of patients diagnosed with breast and gynecologic cancers.
New Drug Combination Shown to be Effective for Patients with Advanced Ovarian Cancer
Lighting the Way for Improved Detection of Ovarian Cancer
Breast Cancer Surveillance Following Ovarian Cancer in BRCA Mutation Carriers
A Novel Treatment For Platinum-Resistant Ovarian Cancer
Racial Disparities in Non-Recommendation of Adjuvant Chemotherapy in Ovarian Cancer
Overall Survival and Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer
Why Black Women with Ovarian Cancer Require Greater Focus
Ovarian Cancer Update
Sugary Food and Beverage Consumption and the Risk of Developing Ovarian Cancer
Do Annual Screenings Reduce Risk of Death in Ovarian Cancer?
Intrauterine Device May Reduce Ovarian Cancer Risk by 30%
Genital Powder Use and Epithelial Ovarian Cancer
No Survival Benefit from Annual Ovarian Cancer Screening in Low-Risk Women
Oral Contraceptives May Reduce Risk of Ovarian Cancer in BRCA Carriers
Improved Ovarian Cancer Patient Survival Rates for Patients With bevacizumab
Use of Hair Products in Relation to Ovarian Cancer Risk
Association Between Breastfeeding and Ovarian Cancer Risk
Women With Ovarian Cancer at Higher Risk for Mental Health Disorders
Time-Dependent Effects of Oral Contraceptive Use on Breast, Ovarian, and Endometrial Cancers
Drug Boosts Survival for Women with Advanced Ovarian Cancer
